Business Description
Trevena Inc
NAICS : 325412
SIC : 2834
ISIN : US89532E1091
Description
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.36 | |||||
| Equity-to-Asset | -1.22 | |||||
| Debt-to-Equity | -1.61 | |||||
| Debt-to-EBITDA | -1.22 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -48.94 | |||||
| Beneish M-Score | -7.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -25.8 | |||||
| 3-Year EBITDA Growth Rate | 20.4 | |||||
| 3-Year EPS without NRI Growth Rate | 17 | |||||
| 3-Year FCF Growth Rate | 14.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 33.33 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.59 | |||||
| 9-Day RSI | 41.88 | |||||
| 14-Day RSI | 41.73 | |||||
| 3-1 Month Momentum % | -76.02 | |||||
| 6-1 Month Momentum % | -80.49 | |||||
| 12-1 Month Momentum % | -87.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.42 | |||||
| Quick Ratio | 2.42 | |||||
| Cash Ratio | 2.21 | |||||
| Days Inventory | 207.24 | |||||
| Days Sales Outstanding | 119.66 | |||||
| Days Payable | 378.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -39.3 | |||||
| Shareholder Yield % | -942.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -190.48 | |||||
| Operating Margin % | -5880.04 | |||||
| Net Margin % | -6233.7 | |||||
| FCF Margin % | -4961.72 | |||||
| ROA % | -107.03 | |||||
| ROIC % | -476.27 | |||||
| 3-Year ROIIC % | 45.13 | |||||
| ROC (Joel Greenblatt) % | -674.08 | |||||
| ROCE % | -122.46 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.69 | |||||
| EV-to-EBIT | -0.82 | |||||
| EV-to-EBITDA | -0.83 | |||||
| EV-to-Revenue | 46.67 | |||||
| EV-to-Forward-Revenue | 8.5 | |||||
| EV-to-FCF | -0.94 | |||||
| Earnings Yield (Greenblatt) % | -121.95 | |||||
| FCF Yield % | -1940.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TRVN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Trevena Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.546 | ||
| EPS (TTM) ($) | -48.89 | ||
| Beta | 0.99 | ||
| 3-Year Sharpe Ratio | -1.47 | ||
| 3-Year Sortino Ratio | -1.64 | ||
| Volatility % | 66.67 | ||
| 14-Day RSI | 41.73 | ||
| 14-Day ATR ($) | 0.288448 | ||
| 20-Day SMA ($) | 1.70016 | ||
| 12-1 Month Momentum % | -87.47 | ||
| 52-Week Range ($) | 1.13 - 19.2325 | ||
| Shares Outstanding (Mil) | 0.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Trevena Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Trevena Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Trevena Inc Frequently Asked Questions
What is Trevena Inc(TRVN)'s stock price today?
The current price of TRVN is $1.62. The 52 week high of TRVN is $19.23 and 52 week low is $1.13.
When is next earnings date of Trevena Inc(TRVN)?
The next earnings date of Trevena Inc(TRVN) is 2025-04-01 Est..
Does Trevena Inc(TRVN) pay dividends? If so, how much?
Trevena Inc(TRVN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers